Literature DB >> 32549920

Screening of multiple hemoprotein-specific aptamers and their applications for the binding, quantification, and extraction of hemoproteins in a microfluidic system.

Chih-Hung Wang1, Gwo-Bin Lee.   

Abstract

The blood hemoproteins, albumin, γ-globulin, and fibrinogen, serve as biomarkers for a variety of human diseases, including kidney and hepatorenal syndromes. Therefore, there is a need to quickly and accurately measure their concentrations in blood. Herein, nucleic acid aptamers demonstrating high affinity and specificity toward these hemoproteins were selected via systematic evolution of ligands by exponential enrichment, and their ability to capture their protein targets was assessed with sodium dodecyl sulfate-polyacrylamide gel electrophoresis followed by a tetramethyl benzidine assay. The limits of detection for the hemoproteins were all around 10-3 μM, and dissociation constant values of 131, 639, and 29nM were obtained; capture rates were measured to be 66%, 71%, and 61%, which is likely to be suitable for clinical diagnostics. Furthermore, a multi-layer microfluidic disk system featuring hemoprotein-specific aptamers for depleting hemoproteins was demonstrated. It could be a promising approach to use aptamers to replace conventional antibodies.
Copyright © 2020 Author(s).

Entities:  

Year:  2020        PMID: 32549920      PMCID: PMC7156270          DOI: 10.1063/1.5141871

Source DB:  PubMed          Journal:  Biomicrofluidics        ISSN: 1932-1058            Impact factor:   2.800


  43 in total

Review 1.  Diagnosis and Management of Heart Failure in Long-Term Dialysis Patients.

Authors:  Ashraf S Abdo
Journal:  Curr Heart Fail Rep       Date:  2017-10

2.  Selection of aptamers specific for glycated hemoglobin and total hemoglobin using on-chip SELEX.

Authors:  Hsin-I Lin; Ching-Chu Wu; Ching-Hsuan Yang; Ko-Wei Chang; Gwo-Bin Lee; Shu-Chu Shiesh
Journal:  Lab Chip       Date:  2015-01-21       Impact factor: 6.799

3.  Searching for biomarkers in clinical practice: the prevalence and clinical significance of hypergammaglobulinemia in inflammatory bowel disease patients.

Authors:  Cristiano Pagnini; Francesca Menasci; Federico Desideri; Arianna Sanna; Vito D Corleto; Gianfranco Delle Fave
Journal:  J Gastrointestin Liver Dis       Date:  2016-12       Impact factor: 2.008

Review 4.  Fibrin(ogen) and thrombotic disease.

Authors:  R A S Ariëns
Journal:  J Thromb Haemost       Date:  2013-06       Impact factor: 5.824

5.  Artificial Antibody with Site-Enhanced Multivalent Aptamers for Specific Capture of Circulating Tumor Cells.

Authors:  Lukuan Liu; Kaiguang Yang; Hang Gao; Xiao Li; Yuanbo Chen; Lihua Zhang; Xiaojun Peng; Yukui Zhang
Journal:  Anal Chem       Date:  2019-01-29       Impact factor: 6.986

6.  Low Albumin Levels Are Associated with Mortality Risk in Hospitalized Patients.

Authors:  Amit Akirov; Hiba Masri-Iraqi; Alaa Atamna; Ilan Shimon
Journal:  Am J Med       Date:  2017-08-09       Impact factor: 4.965

Review 7.  Plasma protein measurements as a diagnostic aid.

Authors:  C A Alper
Journal:  N Engl J Med       Date:  1974-08-08       Impact factor: 91.245

Review 8.  Use of human immunoglobulins as an anti-infective treatment: the experience so far and their possible re-emerging role.

Authors:  Jordi Bozzo; Juan I Jorquera
Journal:  Expert Rev Anti Infect Ther       Date:  2017-05-15       Impact factor: 5.091

Review 9.  Fibrinogen and Fibrin in Hemostasis and Thrombosis.

Authors:  Sravya Kattula; James R Byrnes; Alisa S Wolberg
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-03       Impact factor: 8.311

10.  End-stage renal disease in Taiwan: a case-control study.

Authors:  Su-Ying Tsai; Hung-Fu Tseng; Hsiu-Fen Tan; Yu-Shu Chien; Chia-Chu Chang
Journal:  J Epidemiol       Date:  2009-06-20       Impact factor: 3.211

View more
  1 in total

1.  A practical microfluidic pump enabled by acoustofluidics and 3D printing.

Authors:  Adem Ozcelik; Zeynep Aslan
Journal:  Microfluid Nanofluidics       Date:  2021-01-04       Impact factor: 2.529

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.